Daniel Shortt
dshortt90
The FDA just released a report titled "Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research." This is a non-binding, draft guidance but does inform the FDA's thinking on things
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.